Nontuberculous Mycobacterial Pneumonia Caused by Mycobacterium immunogenum: A Case Report and Literature Review
Abstract
BACKGROUND: Mycobacterium immunogenum is a rare nontuberculous mycobacterium belonging to the Mycobacterium chelonae-abscessus group. Most cases reported in the past decade have been extrapulmonary infections, and reports of nontuberculous mycobacterial pulmonary disease (NTM-PD) caused by M. immunogenum are rare. Herein, we report a case of NTM-PD caused by M. immunogenum.
CASE PRESENTATION: An 81-year-old man with a history of chronic kidney disease and cardiovascular disease was hospitalised in 2021 owing to pneumonia. Two sputum cultures tested positive for Mycobacterium. The mycobacterium biochip test identified M. abscessus and Mycobacterium gilvum, and whole-genome sequencing confirmed the identity as M. immunogenum. Antimicrobial drug susceptibility testing showed that the isolate was resistant to imipenem, moxifloxacin, and doxycycline; intermediately sensitive to tobramycin and linezolid; and sensitive to amikacin, cefoxitin, and clarithromycin. The patient was treated with cefoperazone sodium and sulbactam sodium (2 g twice daily) and switched to meropenem (0.5 g every 6 hours) for anti-infection but died due to acute respiratory failure and severe pneumonia before targeted treatment for NTM-PD could be initiated.
CONCLUSION: NTM-PD is frequently diagnosed at an advanced stage, primarily because its clinical presentation is often atypical and definitive laboratory tests are not readily available. Therefore, greater attention should be paid to the diagnosis and…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Structural and topological analysis of thiosemicarbazone-based metal complexes: computational and experimental study of bacterial biofilm inhibition and antioxidant activity
- Toward better cures for Mycobacterium abscessus lung disease
- Challenges for global antibiotic regimen planning and establishing antimicrobial resistance targets: implications for the WHO Essential Medicines List and AWaRe antibiotic book dosing
- Design, Synthesis and In vitro Antitubercular Effect of New Chalcone Derivatives Coupled with 1,2,3‐Triazoles: A Computational Docking Techniques
- Upregulation of pmrA, pmrB, pmrC, phoQ, phoP, and arnT genes contributing to resistance to colistin in superbug Klebsiella pneumoniae isolates from human clinical samples in Tehran, Iran
- Whole-genome sequencing of clinical isolates of Citrobacter Europaeus in China carrying blaOXA−48 and blaNDM−1
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.